HOME › Press Releases › U.S. Healthcare BPO Market worth $141.7 Billion By 2018
U.S. Healthcare BPO Market worth $141.7 Billion By 2018
The ”U.S. Healthcare BPO Market - Payer (Claims Processing, HR Services, and Finance and Accounts), Provider (Medical Billing and Coding), and Pharmaceutical (Clinical Trials, Contract Manufacturing, and Non-Clinical Services) - Trends and Global Forecasts to 2018 ”,analyzes and studies the major market drivers, restraints, and opportunities in the U.S.
Browse 26 market data tables and 36 figures spread through 259 pages and in-depth TOC on “U.S. Healthcare BPO Market - Payer (Claims Processing, HR Services, and Finance and Accounts), Provider (Medical Billing and Coding), and Pharmaceutical (Clinical Trials, Contract Manufacturing, and Non-Clinical Services) - Trends and Global Forecasts to 2018”.
Early buyers will receive 10% customization on reports.
This report studies the U.S. healthcare BPO market for payer, provider, and pharmaceutical outsourcing for the forecast period 2013 – 2018.
With the ever-changing landscape of the U.S. healthcare system, the U.S. healthcare BPO market is undergoing a significant transformation. The U.S. healthcare payer, provider, and pharmaceutical outsourcing markets are valued at $11.1 billion, $6.8 billion, and $65.6 billion, respectively, in the year 2013.
The U.S. healthcare payer market has been greatly impacted by the introduction of the Patient Protection and Affordable Care Act (PPACA). This market is particularly driven by claims processing services. As the act expanded insurance access to more than 30 million U.S. citizens, the increased claims processing workload led to large-scale outsourcing of these services by payers. The pivotal factors driving the growth of the U.S. healthcare provider outsourcing market include the ICD-10 conversion reform and the shortage of skilled personnel, particularly medical coders in the U.S. The demand for outsourced services in the U.S. pharmaceutical industry has increased immensely over the years as pharmaceutical companies are adopting various strategies like downsizing and consolidation of infrastructure in response to a sharp global economic downturn.
The players in the payer and provider outsourcing market are Accenture (Ireland), Medusind (U.S.), GeBBS Healthcare (U.S.), and Genpact Limited (Bermuda), among others. Lonza (Switzerland), Catalent (U.S.), Boehringer Ingelheim (Germany), and DSM Pharma (U.S.) are some of the CMOs in the market, while some of the players in the CRO space are Quintiles (U.S.), Covance (U.S.), PPD (U.S.), Parexel (U.S.), and Charles Rivers Laboratories (U.S.).
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. M&M covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252